Scailyte

Scailyte

Biotechnologie

True precision medicine through single-cell science.

Info

True precision medicine through single-cell science. Scailyte, a pioneer in AI-driven biomarker discovery from single-cell omics data, has leveraged its proprietary AI platform, ScaiVision, to analyze over 60 million single-cell profiles. The company's extensive network of clinical partners and access to unique patient cohorts in oncology and auto-immunity have led to the development of multiple patent-pending biomarker signatures. Headquartered in Basel, Switzerland, Scailyte collaborates with clinical-stage biotech and pharma companies worldwide, enabling biomarker-driven drug development and paving the way for precision medicine to become a reality. If you want to partner with, reach out to contact@scailyte.com More information about our company, technology & services you can find on our website - https://scailyte.com

Website
https://scailyte.com/
Branche
Biotechnologie
Größe
11–50 Beschäftigte
Hauptsitz
Basel
Art
Privatunternehmen
Gegründet
2017
Spezialgebiete
artificial intelligence, diagnostics, single-cell, medtech, biomarker, big data, clinical research, data analysis, software und cytometry

Orte

Beschäftigte von Scailyte

Updates

  • Scailyte hat dies direkt geteilt

    Unternehmensseite von CEO CF anzeigen, Grafik

    5.270 Follower:innen

    Today, we are remembering and celebrating the remarkable achievements by CEO CF Members in 2024 ✨ Peter Nestorov - Scailyte’s Pioneering Work in Diagnostics: Congratulations for their groundbreaking advancements in tissue-based diagnostics. The sale of endometriosis diagnostic assets to Hera Biotech marks a pivotal step in revolutionising women’s health. ✨ Huge congratulations to Pierre Chauvineau and the Sequana Medical NV team for successfully raising €11.5 million in an equity placement! This incredible achievement supports the US commercial launch of their #alfapump® and the development of their innovative #DSR® program, driving advances in treating fluid overload in liver disease, heart failure, and cancer. ✨ Dreamix Joins Forces with Synechron: Big news from Stoyan Mitov and Dreamix! Dreamix has officially joined Synechron, marking a significant milestone of growth and opportunity. This partnership unites innovation, expertise, and vision. ✨ Kudos to Rich Simmonds and ORTHOSON Ltd for achieving FDA Breakthrough Device Designation. Their innovative ultrasound therapy system is set to transform patient care, marking a significant leap forward in medical technology. We’re proud of the outstanding #impact our members are making across sectors! Stay tuned for #Part2 as we continue celebrating their remarkable stories. #Leadership #Innovation #10DaysOfChristmas #CEOImpact

  • Unternehmensseite von Scailyte anzeigen, Grafik

    5.504 Follower:innen

    🌟 Scailyte at the Global Stage of Precision Medicine – PMFG 2024! We are proud to share that our CEO, Peter Nestorov, will present at the Precision Medicine and he Future of Genomics Summit in Doha, Qatar, bringing together global experts to shape the future of healthcare in the Middle East and beyond. 📅 Date: December 3, 2024 ⏰ Time: 14:20 📍 Location: PMFG 2024, Doha, Qatar Peter will unveil new research findings with his talk: 🎙️ AI-driven Identification of Predictive Biomarkers for Neurotoxicity and Clinical Response in CAR T Cell Therapy. As one of the leading hubs for precision medicine, the Middle East is hosting this transformative event, uniting innovators and leaders from across the globe to advance genomics, diagnostics, and therapeutic strategies. Key themes of Precision Medicine and the Future of Genomics (PMFG)Summit 2024 include: 🔬 Advancements in newborn sequencing technologies and early intervention care. 🌍 Innovations in population screening and genomic data integration into healthcare systems. 🎯 Breakthroughs in personalized and precision therapies for complex diseases. Join us at PMFG 2024, December 3-5, 2024, as we celebrate a decade of progress in precision medicine, showcasing the global collaboration driving cutting-edge innovation. Let’s explore the future of genomics together! #PrecisionMedicine #PMFG2024 #Scailyte #GlobalInnovation #Genomics #PersonalizedTherapies #CARTCellTherapy

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von Scailyte anzeigen, Grafik

    5.504 Follower:innen

    🎤  Precision Medicine Takes Center Stage at Pitch-nic 3! 🎤 What an amazing experience at the Swiss Innovation Park's Pitch-nic event yesterday! The innovation forum at the Novartis Campus was buzzing with energy as 20 startups from the Basel Area and Jura showcased their groundbreaking products - from smart medical devices, e-hospitals, targeted drug-delivery to AI-driven drug R&D! Our co-founder and CEO Peter Nestorov pitched Scailyte’s 3-pillar approach for revolutionizing precision medicine: - Access to patient cohorts providing longitudinal samples and treatment outcome information; - Generating clinical-grade single-cell omics data; - Using our best-in-class AI platform to discover and develop predictive biomarkers for treatment response and patient stratification. Big shout-out to Rahel Schneider and Switzerland Innovation Park Basel Area for curating such a vibrant event! #precisionmedicine #singlecell #AI #biotech #innovation #startups #ScaiVision

    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von Scailyte anzeigen, Grafik

    5.504 Follower:innen

    📢 Hot off the press! The latest ScaiDigest explores how Type 2 T cells are redefining cancer immunotherapy. Dive into two groundbreaking Nature Portfolio papers that reveal: - Long-lasting leukemia remission linked to Type 2 CAR T cell function. - A novel interleukin-4 protein that rejuvenates exhausted T cells. These discoveries, fueled by single-cell omics, challenge the status quo and pave the way for exciting new treatment strategies. #singlecellomics #cancerimmunotherapy #type2immunity #precisionmedicine #ScaiDigest

    Exploring Type 2 T Cell Immunity in Cancer—A Single-Cell Revolution

    Exploring Type 2 T Cell Immunity in Cancer—A Single-Cell Revolution

    Scailyte auf LinkedIn

  • Unternehmensseite von Scailyte anzeigen, Grafik

    5.504 Follower:innen

    🔬 Advancing Diagnostics Through Multi-Omics We’re thrilled to see how the field of precision medicine continues to innovate! Caris Life Sciences’ recent FDA approval for their MI Cancer Seek tumor profiling assay is a game-changer in cancer diagnostics. This multi-cancer companion diagnostic combines 🧬 whole exome sequencing (WES) and 🧬 whole transcriptome sequencing (WTS) in a single workflow—a first in the field. 🧾 By analyzing both DNA and RNA simultaneously from tumor tissue, the test provides actionable insights from 228 genes, covering complex biology such as microsatellite instability (MSI) status, tumor mutational burden (TMB), and key oncogenic mutations like PIK3CA, BRAF, and EGFR. This streamlined approach reduces the need for multiple biopsies and accelerates clinical decision-making for targeted therapies in multiple cancer indications. It predicts response to therapies such as: - Piqray (alpelisib) for PIK3CA-mutated breast cancer - Vectibix (panitumumab) for KRAS/NRAS wild-type colorectal cancer - BRAF/MEK inhibitors like Mekinist (trametinib) for melanoma - Immune checkpoint inhibitors like Keytruda (pembrolizumab) and Jemperli (dostarlimab) for MSI-high tumors - Keytruda + Lenvima for endometrial carcinoma At Scailyte, we recognize the critical importance of translating complex biological insights into clinically applicable assays. While we leverage the unparalleled resolution of single-cell omics for discovery, our end goal is to develop accessible, clinically feasible tests, such as NGS-based panels or targeted qPCR assays, to ensure that these discoveries reach patients. Complex diseases like cancer demand the high-resolution insights of single-cell technologies during the discovery phase, but it’s the ability to translate these findings into robust, scalable solutions that makes a true impact in precision medicine—and that’s where Scailyte excels. This is the future of diagnostics—integrating complex datasets for tailored therapies and better patient outcomes. 👏 Kudos to Caris for leading the charge, and here’s to more breakthroughs across the industry! https://lnkd.in/dckGpAEx #PrecisionMedicine #Diagnostics #SingleCellAnalysis #BiomarkerDiscovery #Oncology #MultiOmics

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von Scailyte anzeigen, Grafik

    5.504 Follower:innen

    📣 We’re thrilled to announce that our CEO, Peter Nestorov will join the innovative minds at Pitch Nic on 📅 November 21 at the 🏢 Novartis Campus, hosted by Switzerland Innovation Park Basel Area and DayOne. This invitation-only event brings together pioneering healthtech startups to showcase cutting-edge innovations shaping the future of healthcare. 💡 Peter will share our latest advancements in precision medicine, leveraging Scailyte's unique single-cell analysis platform to drive real, translatable insights for patient care. We’re proud to be part of this vibrant Swiss biotech ecosystem, alongside remarkable innovators like Zoundream, Doccla, OncoSwab, and others, all working towards transformative solutions in diagnostics, digital health, and AI-driven therapies. 🌱 The event is open to all Novartis employees, and Scailyte can invite external guests interested in the future of precision medicine. If you’d like to attend, don’t hesitate to reach out to us. Together, let’s accelerate the future of healthcare and revolutionize patient outcomes! Stay tuned for more updates. Thomas Peters Ulrike Naumann Sophia Wild #SingleCellAnalysis #Scailyte #PrecisionMedicine #SwissBiotech #Novartis #BaselArea #PitchNic2023 #InnovationInHealthcare

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von Scailyte anzeigen, Grafik

    5.504 Follower:innen

    🌟 Join Us at Global Entrepreneurship Week Basel! 🌟 Scailyte is thrilled to be part of the Global Entrepreneurship Week (GEW) in Basel, happening from November 18 to 24, 2024. This exciting week is dedicated to celebrating and fostering the entrepreneurial spirit in our vibrant city. What is GEW Basel? GEW Basel is a dynamic series of events designed to inspire, connect, and support entrepreneurs. From hands-on workshops to insightful panel discussions and the elegant Basel Entrepreneurship Night, there’s something for everyone passionate about innovation and business. Why is it Interesting? - Networking Opportunities: Meet and connect with like-minded entrepreneurs, investors, and industry experts. - Inspiring Sessions: Gain insights from successful entrepreneurs and thought leaders. - Hands-On Workshops: Enhance your skills and knowledge through practical sessions. Who Should Attend? Whether you’re a seasoned entrepreneur, a startup enthusiast, or someone with a budding business idea, GEW Basel offers invaluable opportunities to learn, network, and grow. Special Highlight: We are proud to announce that our co-founder & CEO Peter Nestorov will be participating in a panel discussion during the week - find more details and the registration link in the post from Seema M.). Don’t miss this chance to hear from one of the leading voices in the Basel startup community! Let’s come together to celebrate entrepreneurship and drive innovation forward! 🚀 #GEWBasel #Entrepreneurship #Innovation #Networking #Scailyte #Basel #startup Basel Area Business & Innovation Switzerland Innovation Park Basel Area

    Profil von Seema M. anzeigen, Grafik

    Co-Founder @ Pinkstripes | Global Leadership Accelerator for Women in Tech and Innovation | Award Winning Entrepreneur | Ecosystem Builder| Executive Coach

    🚀 Join us during Global Entrepreneurship Week Basel! 🌍 https://www.gewbasel.ch/ We are looking forward to kicking off a supportive community for founders , innovators, corporate supporters, investors come be a part of it!! Are you a founder looking for real connections, mentorship, and opportunities to grow? Founders Connect is here to support you every step of the way! 🌟 What You Get When You Join: 🤝 Access to a network of seasoned and ambitious founders and mentors 💡 Exclusive events and resources designed for growth 💼 Opportunities to connect with investors and partners Speakers: 🎤 Maria Hahn - Scaling beyond Switzerland and Innovation in Health 🎤 Peter Nestorov Precision Medicine 🎤 Jennifer Cain Birkmose - Patient Access 🎤 Roberto Iannone - Zoundream 🎤 Thomas Nirnberger - BioFi AG 📅 Date: 21 November 6 pm to 8.30 pm 🗣️ Panel, Q&A, and Networking—connect with global experts and equip your startup for success! 👉 Don’t miss out—Register here Register https://lnkd.in/dcDDxE_M Alain Bindels Olivier Schwartz Thomas Brenzikofer Stefano Roserba Jasna Canadi Semadeni Impact Hub Basel Global Entrepreneurship Network #FoundersConnect #pinkstripes #GEW2024 #Entrepreneurship

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von Scailyte anzeigen, Grafik

    5.504 Follower:innen

    🚆 Our CEO recently concluded a roadshow in Denmark, which culminated in presenting Scailyte at the Genomics for Health symposium in Odense. We invite you to check out his insights and share your thoughts on the strengths and achievements of the Danish biomedical research ecosystem.

    Just back from an inspiring trip to Denmark! 🇩🇰 Last week, I had the opportunity to connect with several pharma and bioinformatics companies and present at the Genomics for Health symposium at the University of Southern Denmark in Odense. It was incredible to share the stage with leading academics and industry experts. A huge thank you to Prof. Vijay Tiwari and Prof. mads thomassen for organizing such a stimulating event! Here are some key takeaways that highlight Denmark's commitment to precision medicine: 📊 Data Powerhouse: Denmark possesses an incredible wealth of clinical data and patient cohorts, built over nearly 50 years of centralized, structured collection. This has enabled groundbreaking research, including a recent GWAS study on psychiatric disorders with over 150k patient samples, led by Prof. Anders Borglum 💡 Foundation-Fueled Innovation: Private foundations associated with the Danish pharmaceutical companies Leo Pharma, Novo Nordisk, and Lundbeck play a crucial role in driving research. They grant an estimated 7-8 billion DKK (approximately 1 billion USD) annually, resulting in state-of-the-art research facilities and unique datasets. This is fueling numerous scientific and translational studies, placing Denmark in the top10 in the global innovation index. Denmark's dedication to data-driven healthcare is truly impressive. It underscores the power of long-term investment in research infrastructure, large-scale data collection and collaboration to advance precision medicine. #precisionmedicine #genomics #bioinformatics #Denmark #healthcareinnovation

    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von Scailyte anzeigen, Grafik

    5.504 Follower:innen

    🔍 Get ready for the groundbreaking world of AI-powered protein folding! In this month's ScaiDigest, our senior data scientist Sukalp Muzumdar, PhD breaks down the science behind 🧬 AlphaFold2 and highlights AI's potential to solve the hard challenges in biology. 🔬 #AINobel #AlphaFold2 #StructuralBiology #Scailyte #ScaiDigest #DataScience #AI #DeepLearning #Innovation #Science

    The Year of the AI Nobel

    The Year of the AI Nobel

    Scailyte auf LinkedIn

Verbundene Seiten

Ähnliche Seiten

Finanzierung

Scailyte Insgesamt 9 Finanzierungsrunden

Letzte Runde

Serie A

1.800.693,00 $

Weitere Informationen auf Crunchbase